©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: BI Sky Global
Innocan Pharma Reports First Quarter 2025 Financial Results
HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation reported its financial consolidated results for the first quarter ended March 31, 2025.
First Quarter 2025 Financial Highlights
Revenues increased...
Innocan Pharma Granted Mexican Patent for Topical Pain Relief Product
HERZLIYA, Israel, and CALGARY, AB -- The Mexican patent office has issued a notice of allowance for Innocan Pharma Corporation's patent application covering its proprietary topical pain-relief technology.
The...
Innocan Pharma Reports Full-Year 2024 Results
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, reported its audited financial...
Innocan Pharma Subsidiary BI Sky Global Completes FDA MoCRA Registration
HERZLIYA, Israel, and CALGARY, Alberta -- BI Sky Global, a subsidiary of Innocan Pharma Corporation, a pioneer in the pharmaceutical and biotechnology industries, completed the registration...
Innocan Pharma Reports Full Year 2023 Results
HERZLIYA, Israel, and CALGARY, Alberta -- Innocan Pharma Corporation, a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce...